Recent Updates
Recently added Catalysts
CTNM Positive Sentiment

Contineum Therapeutics to Present at the 2026 Morgan Stanley Global Healthcare Conference

Tuesday, August 25, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Contineum Therapeutics, a clinical-stage biopharmaceutical company, will present at the 2026 Morgan Stanley Global Healthcare Conference. The presentation is scheduled for September 15th at 5:35 p.m. ET. This event underscores the company's focus on developing therapies for inflammatory and fibrotic diseases.

Market Sentiment Analysis

POSITIVE FACTORS

  • Contineum Therapeutics is recognized for its innovative therapies.
  • The presentation at a major conference highlights the company's visibility.
  • Management's participation indicates confidence in their pipeline.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+79%
120-day peak, hindsight
Typical move
6.4%
average across 3 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
PIPE-307 Dose A
Phase 2 · Relapsing Remitting Multiple Sclerosis

Full Press Release Details

SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that management is scheduled to present at the 2026 Morgan Stanley Global Healthcare Conference on Tuesday, September 15th at 5:35 p.m. ET. An audio webcast of the fireside chat can be accessed on the Investors section of

Frequently Asked Questions

When will Contineum Therapeutics present?

Contineum Therapeutics is scheduled to present on September 15th, 2026.

What conference will Contineum participate in?

Contineum Therapeutics will participate in the Morgan Stanley Global Healthcare Conference.

What time is the presentation at the conference?

The presentation is set for 5:35 p.m. ET.

Where can I access the presentation?

An audio webcast of the presentation will be available in the Investors section.

ShareAdd on Google
Tags: CTNM Viatris Investor Conferences Healthcare Contineum Therapeutics Morgan Stanley Global Healthcare Conference biopharmaceuticals
Last updated: Aug 25, 2026

Biotech snapshot

Cash runway
$237M liquidity · $4M/mo burn
~61 mo
Minimal dilution risk
Lead asset
PIPE-307 Dose APhase 2
Relapsing Remitting Multiple Sclerosis →

Catalyst track record

+79%
best trade around CTNM's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for CTNM.

See every catalyst's timing & PoA →